Latest News about NVO
Recent news which mentions NVO
Forecasting The Future: 7 Analyst Projections For Novo Nordisk
November 06, 2024
Tickers
NVO
From Benzinga
From Benzinga
Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
November 06, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
From Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
November 05, 2024
From Benzinga
From Benzinga
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
November 04, 2024
From Benzinga
What's Going On With Hims & Hers Health Stock Monday?
November 04, 2024
From Benzinga
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
November 04, 2024
From Benzinga
Could This Near Trillion-Dollar Stock Be a Millionaire Maker?
November 03, 2024
From Motley Fool
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
From Benzinga
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
October 30, 2024
From Benzinga
From Benzinga
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
October 30, 2024
From Motley Fool
1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever
October 29, 2024
From Motley Fool
Neuralink's Promise For Alzheimer's Has A Crucial Time Window — Elon Musk Explains Why
October 29, 2024
From Benzinga
Tickers
NVO
From Motley Fool
Benzinga Bulls And Bears: Nvidia, Tesla, MicroStrategy, Plug Power — And Crypto Traders Anticipate Dogecoin Topping 50 Cents
October 26, 2024
From Benzinga
Ozempic Can Potentially Cut Risk Of Alzheimer's Compared To Other Diabetic Medicines, Study Shows
October 24, 2024
From Benzinga
Hims & Hers Stock Dropped: Here's What You Need to Know
October 24, 2024
From Motley Fool
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.